High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma (Q31994979)

5 July 2017

title

High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma (English)

1 reference

5 July 2017

1 reference

H Kim

1

1 reference

5 July 2017

P Likhari

2

1 reference

5 July 2017

D Parker

3

1 reference

5 July 2017

P Statkevich

4

1 reference

5 July 2017

A Marco

5

1 reference

5 July 2017

C C Lin

6

1 reference

5 July 2017

A A Nomeir

7

1 reference

5 July 2017

publication date

1 January 2001

1 reference

Journal of Pharmaceutical and Biomedical Analysis

5 July 2017

published in

1 reference

5 July 2017

volume

24

1 reference

5 July 2017

issue

3

1 reference

5 July 2017

page(s)

461-468

1 reference

Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

Phase II evaluation of mitozolomide in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

Methylation of nucleic acids and urinary excretion of 14 C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole5(4)-carboxomide.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2800%2900466-0

7 January 2021

10.1016/S0731-7085(00)00466-0

Identifiers

DOI

1 reference

5 July 2017

1 reference